CharlestonPharma Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Debt
  • Latest Deal Amount
  • $200K
Latest Deal Amount
  • Investors
  • 4

CharlestonPharma General Information

Description

Developer of anti-nucleolin antibodies designed to offer related diagnostic tests for cancer patients. The company is engaged in developing fully human monoclonal antibodies that specifically target nucleolin located in the plasma membrane and cytoplasm of tumor cells, providing healthcare providers with antibodies to treat cancer patients as well as the use of cell surface nucleolin in the prognosis and diagnosis of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 645 Meeting Street
  • Suite 4
  • Charleston, SC 29403
  • United States
+1 (843) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CharlestonPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Debt - General 03-Jun-2015 $200K 00.00 Completed Generating Revenue
7. Later Stage VC 01-Jan-2015 00000 00.00 00.000 Completed Generating Revenue
6. Early Stage VC 01-Jan-2013 00.00 00.00 Completed Generating Revenue
5. Early Stage VC 14-Dec-2012 00000 00000 Completed Generating Revenue
4. Early Stage VC 07-Dec-2012 00000 Completed Generating Revenue
3. Debt - General 07-Dec-2012 00000 00000 Completed Generating Revenue
2. Debt - General 04-Oct-2011 $200K $200K Completed Generating Revenue
1. Grant 12-Apr-2011 $25K Completed Generating Revenue
To view CharlestonPharma’s complete valuation and funding history, request access »

CharlestonPharma Executive Team (3)

Name Title Board Seat Contact Info
Bradford Goodwin Co-Founder & Chief Executive Officer
Daniel Fernandes Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 2 of 3 executive team members. Get the full list »

CharlestonPharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
VentureSouth Angel Group Minority 000 0000 000000 0
Upstate Carolina Angel Network Angel Group Minority 000 0000 000000 0
SC Launch Government Minority 000 0000 000000 0
Sears Capital Management Venture Capital Minority 000 0000 000000 0
To view CharlestonPharma’s complete investors history, request access »